کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2568299 | 1128432 | 2015 | 7 صفحه PDF | دانلود رایگان |
• Tungsten (W) induces cell transformation and increases migration in vitro.
• W increases xenograft growth in nude mice.
• W altered the expression of cancer-related genes such as those involved in leukemia.
• Some of the dysregulated leukemia genes include, CD74, CTGF, MST4, and HOXB5.
• For the first time, data is presented that demonstrates tungsten's carcinogenic potential.
Metals such as arsenic, cadmium, beryllium, and nickel are known human carcinogens; however, other transition metals, such as tungsten (W), remain relatively uninvestigated with regard to their potential carcinogenic activity. Tungsten production for industrial and military applications has almost doubled over the past decade and continues to increase. Here, for the first time, we demonstrate tungsten's ability to induce carcinogenic related endpoints including cell transformation, increased migration, xenograft growth in nude mice, and the activation of multiple cancer-related pathways in transformed clones as determined by RNA sequencing. Human bronchial epithelial cell line (Beas-2B) exposed to tungsten developed carcinogenic properties. In a soft agar assay, tungsten-treated cells formed more colonies than controls and the tungsten-transformed clones formed tumors in nude mice. RNA-sequencing data revealed that the tungsten-transformed clones altered the expression of many cancer-associated genes when compared to control clones. Genes involved in lung cancer, leukemia, and general cancer genes were deregulated by tungsten. Taken together, our data show the carcinogenic potential of tungsten. Further tests are needed, including in vivo and human studies, in order to validate tungsten as a carcinogen to humans.
Journal: Toxicology and Applied Pharmacology - Volume 288, Issue 1, 1 October 2015, Pages 33–39